GOP senators urge Trump administration to crack down on kratom
- Senators Grassley, Lee, and Collins demand DEA schedule kratom as a controlled substance.
- Targeted compounds include 7-hydroxymitragynine and other synthetic derivatives linked to rising ER visits.
- Kratom industry lobbyists cry foul, claiming the push ignores science and threatens consumer access.
- MAHA PAC ties complicate the optics as industry donors back Kennedy-aligned movements.
Brief Summary
Three Republican senators are putting the squeeze on the DEA and FDA to clamp down on kratom, the controversial herbal supplement currently flooding gas station shelves nationwide. Citing a spike in overdose risks and emergency room visits, the lawmakers are pushing for permanent Schedule I classification for the plant and its synthetic derivatives. The move comes as federal prosecutors link kratom-related products to recent student overdose deaths, setting up a clash between public safety advocates and an industry that has poured significant cash into political groups.
Why This Matters
If you are a regular consumer of gas station wellness supplements or mood boosters, this could mean the end of your access to these products entirely. A Schedule I designation would effectively ban these substances, shifting them from legal supplements to prohibited drugs. Beyond the immediate availability of these products, this fight highlights a growing federal war on unregulated herbal compounds, meaning you should keep a close eye on your local head shop shelves—what is legal today could be a federal crime tomorrow if the DEA decides to move forward with the senators' demands.